Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 3089 - 3096 of 12091 results

Mintz Life Sciences Deal Activity (April – June 2021)
June 30, 2021| Article| Viewpoint

Free Laptops? Paid Fellowships? SCOTUS Redefines NCAA Amateurism Status
June 29, 2021| News

The U.S. Supreme Court Raises the Bar on Standing in Privacy and Data Breach Class Actions
June 29, 2021| Blog| Viewpoint

Pro Bono in a Pandemic: Big Law's COVID Response Gave Security to Those in Need
June 28, 2021| News

Changes in Connecticut’s Data Privacy Laws – But Not As Drastic As It Could Have Been
June 28, 2021| Blog| Viewpoint

New York City Offers Up to $20 million to Projects Selected from Life Sciences Innovation Infrastructure RFP
June 24, 2021| Alert| Viewpoint

Redefining “Business as Usual” in the Time of COVID
June 24, 2021| Advisory| Viewpoint
News & Press Releases
Mintz advised the creators of Morbid, one of the top-charting true crime podcasts, in a multi-year agreement to move to SiriusXM from Wondery. The deal gives SiriusXM exclusive advertising rights for the audio and video formats of the podcast.
Mintz Advises CVC DIF in Acquisition of SBA Communications’ Canadian Tower Infrastructure Platform
August 06, 2025
Mintz advised CVC DIF, the dedicated infrastructure investment strategy of global private markets manager CVC, in its agreement to acquire SBA Communications’ Canadian wireless tower business, one of Canada’s leading independent owners and operators of wireless communications towers. The transaction is expected to close in the fourth quarter of 2025, subject to customary closing conditions.
Mintz advised the underwriters in connection with a $69 million public offering by Larimar Therapeutics, Inc. of 21,562,500 shares of its common stock at a price to the public of $3.20 per share. The gross proceeds to Larimar from the offering were $69 million before deducting underwriting discounts and commissions and other offering expenses.
Events
Podcasts

Mintz On Air: Practical Policies — A Private Equity Non-Compete Primer
July 15, 2025| Podcast|

Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|
